Type: Full or Part-time
Location: United States, Remote
Diviner is seeking a full-time (or part-time) Biotech Equities Analyst to apply a strong understanding of both the science and the business of drug development to research clinical-stage drugs our expert network is assessing.
You have excelled as a therapeutics/biotech analyst on the sell-side, or at an investment firm. You have a passion for therapeutics equities research. You know how to assess company stock valuations via a range of valuation methodologies using multiple information sources. You thrive when collaborating with a small team of peers and senior leaders, partnering with them as you research new opportunities. You enjoy participating in discussions about biotech valuations, seeking valid, data-driven consensus to inform critical company deliverables.
Modeling expertise in determining upside/downside stock price movement based on clinical trial outcomes
This is a fully remote position. Candidates can be based in any time zone within six hours of US EST.
Commensurate with experience and ability. Includes both base pay and stock options.
Diviner is a unique startup applying human-centered prediction science to forecast drug development outcomes and their impact on stock prices.
Diviner is committed to hiring and retaining a diverse workforce. We are proud to be an Equal Opportunity/Affirmative Action-Employer, making decisions without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability status, age, marital status, protected veteran status or any other protected class.
Your application information will be kept confidential according to EEO guidelines.